Yong Wu

No ORCID on file · 4 papers in corpus
other 2026
Genome medicine ·doi:10.1186/s13073-026-01663-5

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a rare aggressive, and chemo-resistant subtype of epithelial ovarian cancer. Current limitations in precisely characterizing its molecular features have resulted in restricted availability …

diagnostic-accuracy 2024
Cell reports. Medicine ·doi:10.1016/j.xcrm.2024.101666

Epithelial ovarian cancer (EOC) is the deadliest women's cancer and has a poor prognosis. Early detection is the key for improving survival (a 5-year survival rate in stage I/II is over 70% compared to that of 25% in stage III/IV) and can b…

2022
·doi:10.22541/au.164622124.48243081/v1

Objective: We aimed to explore the potential mechanism of pelvic lymph node (pLN) metastasis of cervical cancer (CC) by multiplex immunofluorescence (mIF) and construct a nomogram for preoperative prediction of pLN metastasis in patients w…

case-report 2022
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis ·doi:10.1016/j.transci.2022.103458

BACKGROUND: "Asia type" DEL red blood cells (RBCs) express a very weak D antigen and cannot be detected by routine RhD typing. Thus, it is routinely typed as D-negative (D-) blood group and transfused to D- recipients. Here we described a c…